A Prospective Analysis of Quality of Life Data and Clinical Toxicity as a Function of Radiation Dose and Volume in Stage I Lung Cancer Patients after SBRT

Abstract

while preventing other patients with radiation changes or inflammation to avoid unnecessary treatment and associated morbidity. This model needs to be validated in a larger cohort of patients before a generalized use.